OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL-13 is a driver of COVID-19 severity
Alexandra N. Donlan, Tara E. Sutherland, Chelsea Marie, et al.
JCI Insight (2021)
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

The extracellular matrix and the immune system: A mutually dependent relationship
Tara E. Sutherland, Douglas P. Dyer, Judith E. Allen
Science (2023) Vol. 379, Iss. 6633
Open Access | Times Cited: 222

The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
Leandro Moretti, Jack Stalfort, Thomas H. Barker, et al.
Journal of Biological Chemistry (2021) Vol. 298, Iss. 2, pp. 101530-101530
Open Access | Times Cited: 219

Recent developments in the immunopathology of COVID‐19
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 70

SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains
Peter Radvák, Hyung‐Joon Kwon, Martina Košíková, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 94

Cytokine Signature Associated With Disease Severity in COVID-19
Jing Guo, Shuting Wang, Xia He, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 74

Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients
Chiara Giacomelli, Rebecca Piccarducci, Laura Marchetti, et al.
Biochemical Pharmacology (2021) Vol. 193, pp. 114812-114812
Open Access | Times Cited: 62

COVID‐19 immunopathology: From acute diseases to chronic sequelae
Mohd Arish, Wei Qian, Harish Narasimhan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45

Immune determinants of chronic sequelae after respiratory viral infection
Harish Narasimhan, Yue Wu, Nick P. Goplen, et al.
Science Immunology (2022) Vol. 7, Iss. 73
Open Access | Times Cited: 38

The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view
Mihai Lazăr, Mihai Săndulescu, Ecaterina Constanța Barbu, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 639-639
Open Access | Times Cited: 9

PathIntegrate: Multivariate modelling approaches for pathway-based multi-omics data integration
Cecilia Wieder, Juliette Cooke, Clément Frainay, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 3, pp. e1011814-e1011814
Open Access | Times Cited: 9

Association between allergic conditions and COVID-19 susceptibility and outcomes
Chao Chen, Xue Song, Dana J. Murdock, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 132, Iss. 5, pp. 637-645.e7
Open Access | Times Cited: 8

Cross-Platform Comparison of Highly Sensitive Immunoassays for Inflammatory Markers in a COVID-19 Cohort
Koji Abe, Joanne C. Beer, Tran Thuy Nguyen, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 7, pp. 1244-1253
Open Access | Times Cited: 8

Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19
T. Matsuyama, Steven K. Yoshinaga, Kimitaka Shibue, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 12, pp. 3199-3213
Open Access | Times Cited: 48

Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19
Xixi Jing, Min Xu, Deye Song, et al.
Immunity & Ageing (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 37

Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19
Alessandra Soares‐Schanoski, Natalie Sauerwald, Carl Goforth, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33

Biochemical, biophysical, and immunological characterization of respiratory secretions in severe SARS-CoV-2 infections
Michael J. Kratochvil, Gernot Kaber, Sally Demirdjian, et al.
JCI Insight (2022) Vol. 7, Iss. 12
Open Access | Times Cited: 30

IL13Pred: A method for predicting immunoregulatory cytokine IL-13 inducing peptides
Shipra Jain, Anjali Dhall, Sumeet Patiyal, et al.
Computers in Biology and Medicine (2022) Vol. 143, pp. 105297-105297
Closed Access | Times Cited: 29

Treatment with the senolytics dasatinib/quercetin reduces SARS‐CoV ‐2‐related mortality in mice
Andrés Pastor Fernández, Antonio Rodríguez Bertos, Arantzazu Sierra‐Ramírez, et al.
Aging Cell (2023) Vol. 22, Iss. 3
Open Access | Times Cited: 18

Hyaluronan in the pathogenesis of acute and post-acute COVID-19 infection
Henry W. Barnes, Sally Demirdjian, Naomi L. Haddock, et al.
Matrix Biology (2023) Vol. 116, pp. 49-66
Open Access | Times Cited: 17

Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19
Suchitra Kamle, Bing Ma, Chuan He, et al.
JCI Insight (2021) Vol. 6, Iss. 21
Open Access | Times Cited: 34

Oral hymecromone decreases hyaluronan in human study participants
Joelle I. Rosser, Nadine Nagy, Riya Goel, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 9
Open Access | Times Cited: 25

Obesity-Mediated Immune Modulation: One Step Forward, (Th)2 Steps Back
Viviane Schmidt, Andrew E. Hogan, Padraic G. Fallon, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25

Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae
Gustavo Ramírez-Martínez, Luis Jiménez-Álvarez, Alfredo Cruz‐Lagunas, et al.
Journal of Interferon & Cytokine Research (2022) Vol. 42, Iss. 8, pp. 352-368
Open Access | Times Cited: 24

Page 1 - Next Page

Scroll to top